Vaxart shares plummet 50% on disappointing vaccine news

Vaxart (VXRT.US) stock plunged more than 50% during today's session after its experimental oral Covid vaccine showed disappointing preliminary data from its Phase 1 study. The biotechnology company announced that the vaccine was generally well-tolerated, however neutralizing antibodies were not detected among the 20 study participants who received two doses of the drug. Neutralizing antibodies bind to viruses in a way that prevents them from replicating. The company said no severe adverse events were reported in the phase one trial, with side effects generally being mild. Vaxart is still confident that its tablet will not only be able to treat the coronavirus but also handle the emerging new strains of the virus. “Our Phase I results highlight the importance of our differentiated vaccine design, as they suggest VXA-CoV2-1 could have broad activity against existing and future coronavirus strains," Chief Executive Andrei Floroiu said in a statement. Vxart’s Covid vaccine is in a small tablet and can be shipped and stored at room temperature, unlike Pfizer and Moderna’s vaccines.

Vaxart (VXRT.US) launched today’s session with a massive bearish price however buyers managed to find some support at the $8.95 level which is additionally strengthened by 50 SMA (green line). Source: xStation5

10 October 2025, 5:51 PM

Applied Digital accelerates growth. Shares rise by nearly 20%.

10 October 2025, 9:52 AM

DAX: DE40 tries to hold the momentum 📈Brenntag and ArcelorMittal under pressure

9 October 2025, 4:13 PM

Delta Airlines stock lifts off after earnings✈️

9 October 2025, 3:34 PM

Stock of the Week - Super Micro Computer (09.10.2025)

stocks

Cookie name	Description
SERVERID
userBranchSymbol	Expiration date 1 day
test_cookie	Expiration date 1 hour
adobe_unique_id	Expiration date 364 days
__hssc	Expiration date 1 hour
SESSID	Expiration date 1 day
__cf_bm	Expiration date 1 hour
intercom-id-iojaybix	Expiration date 270 days
intercom-session-iojaybix	Expiration date 6 days
xtbCookiesSettings	Expiration date 364 days
TS5b68a4e1027
countryIsoCode
xtbLanguageSettings	Expiration date 364 days
userPreviousBranchSymbol	Expiration date 364 days
intercom-device-id-iojaybix	Expiration date 270 days
__cfruid
_cfuvid

Cookie name	Description
_gid	Expiration date 1 day
_gat_UA-98728395-1	Expiration date 1 hour
_gat_UA-121192761-1	Expiration date 1 hour
_gcl_au	Expiration date 89 days
_ga_CBPL72L2EC	Expiration date 729 days
_ga	Expiration date 729 days
__hstc	Expiration date 179 days
__hssrc
_vwo_uuid_v2	Expiration date 365 days
_ga_TC79BEJ20L	Expiration date 729 days
_vwo_uuid	Expiration date 365 days
_vwo_ds	Expiration date 29 days
_vwo_sn	Expiration date 1 hour
_vis_opt_s	Expiration date 99 days
_vis_opt_test_cookie
af_id	Expiration date 394 days
afUserId	Expiration date 730 days
AF_SYNC	Expiration date 6 days
AnalyticsSyncHistory	Expiration date 29 days

Cookie name	Description
MUID	Expiration date 389 days
_omappvp	Expiration date 3998 days
_omappvs	Expiration date 1 hour
_uetsid	Expiration date 1 day
_uetvid	Expiration date 389 days
_fbp	Expiration date 89 days
fr	Expiration date 89 days
_ttp	Expiration date 89 days
_tt_enable_cookie	Expiration date 89 days
hubspotutk	Expiration date 179 days
IDE	Expiration date 389 days
YSC
VISITOR_INFO1_LIVE	Expiration date 179 days
li_sugr	Expiration date 89 days
guest_id_marketing	Expiration date 729 days
guest_id_ads	Expiration date 729 days
guest_id	Expiration date 729 days
muc_ads	Expiration date 729 days
VISITOR_PRIVACY_METADATA	Expiration date 179 days
MSPTC	Expiration date 389 days

Cookie name	Description
bcookie	Expiration date 364 days
lidc	Expiration date 1 day
UserMatchHistory	Expiration date 29 days
bscookie	Expiration date 364 days
li_gc	Expiration date 179 days
personalization_id	Expiration date 729 days

Vaxart shares plummet 50% on disappointing vaccine news

Join over 1 700 000 XTB Group Clients from around the world